MAY:
- Renalytix selects Eversana to expand commercialization of KidneyIntelX for early-stage kidney disease prognosis detection in patients with type 2 diabetes
APRIL:
- Real-world Utility Data demonstrates KidneyIntelX optimizes clinical management in early-stage CKD across physician specialties
